These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9825114

  • 1. Mechanisms of non-drowsiness after oral administration of TMK688, a novel antiallergic drug.
    Shizawa T, Inaba K, Yoshida F, Iizuka T, Hijikuro K, Yanoshita R, Kamitani T.
    Arzneimittelforschung; 1998 Oct; 48(10):979-84. PubMed ID: 9825114
    [Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory action of orally active 5-lipoxygenase inhibitor TMK688.
    Yamamoto S, Jiang H, Kato R.
    Pharmacology; 1994 May; 48(5):273-82. PubMed ID: 8016188
    [Abstract] [Full Text] [Related]

  • 3. 5-Lipoxygenase inhibitory and antihistamine activities of linetastine.
    Shizawa T, Ohmori S, Maeda K, Sakata K, Ishii T, Kamitani T.
    Arzneimittelforschung; 1996 Nov; 46(11):1072-6. PubMed ID: 8955867
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of two-stage skin carcinogenesis as well as complete skin carcinogenesis by oral administration of TMK688, a potent lipoxygenase inhibitor.
    Jiang H, Yamamoto S, Kato R.
    Carcinogenesis; 1994 May; 15(5):807-12. PubMed ID: 8200079
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effect of TMK688 on skin tumor initiation caused by 7,12-dimethylbenz[a]anthracene in relation to inhibition of aryl hydrocarbon hydroxylase activity and Cyp1a1 mRNA induction.
    Jiang H, Yamamoto S, Ozawa S, Shimada M, Yamazoe Y, Kato R.
    Pharmacology; 1996 Aug; 53(2):123-32. PubMed ID: 8902877
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characteristics of Sho-seiryu-to, an antiallergic Kampo medicine without effects on histamine H1 receptors and muscarinic cholinergic system in the brain.
    Sakaguchi M, Iizuka A, Yuzurihara M, Ishige A, Komatsu Y, Matsumiya T, Takeda H.
    Methods Find Exp Clin Pharmacol; 1996 Aug; 18(1):41-7. PubMed ID: 8721255
    [Abstract] [Full Text] [Related]

  • 7. Studies on the novel antiallergic agent HSR-609: its penetration into the central nervous system in mice and guinea pigs and its selectivity for the histamine H1-receptor.
    Kakiuchi M, Ohashi T, Musoh K, Kawamura K, Morikawa K, Kato H.
    Jpn J Pharmacol; 1997 Apr; 73(4):291-8. PubMed ID: 9165365
    [Abstract] [Full Text] [Related]

  • 8. Effects of TMK688, a novel anti-allergic drug, on allergic nasal obstruction and exudative responses in sensitized guinea pigs.
    Shizawa T, Maeda K, Abe K, Ishii T, Kamitani T.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):815-9. PubMed ID: 9453468
    [Abstract] [Full Text] [Related]

  • 9. The inhibitory effect of TMK688, a novel anti-allergic drug having both 5-lipoxygenase inhibitory activity and anti-histamine activity, against bronchoconstriction, leukotriene production and inflammatory cell infiltration in sensitized guinea pigs.
    Tohda Y, Nakajima S, Shizawa T, Maeda K, Ohmori S, Satoh H, Ishii T, Kamitani T.
    Clin Exp Allergy; 1997 Jan; 27(1):110-8. PubMed ID: 9117875
    [Abstract] [Full Text] [Related]

  • 10. Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative.
    Fukuda S, Midoro K, Yamasaki M, Gyoten M, Kawano Y, Fukui H, Ashida Y, Nagaya H.
    Inflamm Res; 2003 May; 52(5):206-14. PubMed ID: 12813625
    [Abstract] [Full Text] [Related]

  • 11. Dissociation between central and peripheral antihistamine activities of the new antiallergic agent N-[4-[4-(diphenylmethyl)-1-piperazinyl]-butyl]-3-(6-methyl-3-pyridyl) acrylamide in rats and monkeys.
    Ishii K, Yakuo I, Nakagawa H, Nakamura H.
    Arzneimittelforschung; 1993 Jun; 43(6):668-71. PubMed ID: 8102529
    [Abstract] [Full Text] [Related]

  • 12. Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat.
    Pichat P, Angel I, Arbilla S.
    Arzneimittelforschung; 1998 Feb; 48(2):173-8. PubMed ID: 9541729
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent betotastine besilate.
    Kato M, Nishida A, Aga Y, Kita J, Kudo Y, Narita H, Endo T.
    Arzneimittelforschung; 1997 Oct; 47(10):1116-24. PubMed ID: 9368705
    [Abstract] [Full Text] [Related]

  • 14. Antiallergic effect of ZCR-2060: antihistaminic action.
    Abe T, Omata T, Yoshida K, Matsumura T, Ikeda Y, Segawa Y, Matsuda K, Nagai H.
    Jpn J Pharmacol; 1994 Sep; 66(1):87-94. PubMed ID: 7861672
    [Abstract] [Full Text] [Related]

  • 15. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
    Gutiérrez B, Dordal A, Fort M, Galicia J, Farré AJ.
    Methods Find Exp Clin Pharmacol; 1996 Sep; 18(6):397-406. PubMed ID: 8892269
    [Abstract] [Full Text] [Related]

  • 16. [The effect of antihistaminic preparations on the binding of labelled mepyramine, ketanserin and quinuclidinyl benzilate in the rat brain].
    Gankina EM, Porodenko NV, Kondratenko TI, Severin ES, Kaminka ME, Mashkovskiĭ MD.
    Eksp Klin Farmakol; 1993 Sep; 56(1):22-4. PubMed ID: 8100727
    [Abstract] [Full Text] [Related]

  • 17. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [Abstract] [Full Text] [Related]

  • 18. First and second generation H₁ histamine receptor antagonists produce different sleep-inducing profiles in rats.
    Unno K, Ozaki T, Mohammad S, Tsuno S, Ikeda-Sagara M, Honda K, Ikeda M.
    Eur J Pharmacol; 2012 May 15; 683(1-3):179-85. PubMed ID: 22449385
    [Abstract] [Full Text] [Related]

  • 19. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
    Kreutner W, Hey JA, Anthes J, Barnett A, Young S, Tozzi S.
    Arzneimittelforschung; 2000 Apr 15; 50(4):345-52. PubMed ID: 10800633
    [Abstract] [Full Text] [Related]

  • 20. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice.
    Swiader M, Wielosz M, Czuczwar SJ.
    Eur Neuropsychopharmacol; 2004 Aug 15; 14(4):307-18. PubMed ID: 15163441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.